$66.90
0.15% today
NYSE, Sep 03, 05:50 pm CET
ISIN
US26622P1075
Symbol
DOCS

Doximity Stock price

$67.00
+8.70 14.92% 1M
-1.45 2.12% 6M
+13.61 25.49% YTD
+30.22 82.16% 1Y
+34.32 105.02% 3Y
+14.00 26.42% 5Y
+14.00 26.42% 10Y
+14.00 26.42% 20Y
NYSE, Closing price Tue, Sep 02 2025
-0.94 1.38%
ISIN
US26622P1075
Symbol
DOCS

Key metrics

Basic
Market capitalization
$12.6b
Enterprise Value
$11.7b
Net debt
positive
Cash
$841.0m
Shares outstanding
187.5m
Valuation (TTM | estimate)
P/E
57.3 | 43.2
P/S
21.3 | 19.4
EV/Sales
19.9 | 18.1
EV/FCF
40.8
P/B
12.2
Financial Health
Equity Ratio
85.6%
Return on Equity
20.6%
ROCE
22.6%
ROIC
87.4%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$589.6m | $646.5m
EBITDA
$247.2m | $347.4m
EBIT
$236.3m | $339.8m
Net Income
$235.1m | $290.5m
Free Cash Flow
$287.3m
Growth (TTM | estimate)
Revenue
19.5% | 13.3%
EBITDA
29.8% | 44.3%
EBIT
31.1% | 47.7%
Net Income
46.5% | 30.2%
Free Cash Flow
77.1%
Margin (TTM | estimate)
Gross
90.1%
EBITDA
41.9% | 53.7%
EBIT
40.1%
Net
39.9% | 44.9%
Free Cash Flow
48.7%
More
EPS
$1.2
FCF per Share
$1.5
Short interest
3.3%
Employees
830
Rev per Employee
$690.0k
Show more

Is Doximity a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Doximity Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Doximity forecast:

15x Buy
58%
11x Hold
42%

Analyst Opinions

26 Analysts have issued a Doximity forecast:

Buy
58%
Hold
42%

Financial data from Doximity

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
590 590
19% 19%
100%
- Direct Costs 58 58
14% 14%
10%
532 532
20% 20%
90%
- Selling and Administrative Expenses 195 195
14% 14%
33%
- Research and Development Expense 97 97
18% 18%
16%
247 247
30% 30%
42%
- Depreciation and Amortization 11 11
6% 6%
2%
EBIT (Operating Income) EBIT 236 236
31% 31%
40%
Net Profit 235 235
46% 46%
40%

In millions USD.

Don't miss a Thing! We will send you all news about Doximity directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Doximity Stock News

Neutral
Business Wire
8 days ago
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors. Investors who have continuously held Doximity shares since before June 24, 2021, may have legal rights and are encouraged to contact the ...
Neutral
Seeking Alpha
27 days ago
Doximity, Inc. (NYSE:DOCS ) Q1 2026 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Anna Bryson - Chief Financial Officer Jeffrey A. Tangney - Co-Founder, CEO & Chairperson Perry Scott Gold - Head of Investor Relations Conference Call Participants Allen Charles Lutz - BofA Securities, Research Division Brian Christopher Peterson - Raymond James & Associates, Inc., Resear...
Neutral
The Motley Fool
27 days ago
Doximity (DOCS) Q1 Revenue Rises 15%
More Doximity News

Company Profile

Doximity, Inc. operates an online platform for medical professionals. It's cloud-based software has the ability to enable the users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. The company was founded by Konstantin Guericke, Nate Gross and Jeffrey A. Tangney in April 16, 2010 and is headquartered in San Francisco, CA.

Head office United States
CEO Jeffrey Tangney
Employees 830
Founded 2010
Website www.doximity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today